Proton magnetic resonance spectroscopy of brain-stem lesions

被引:26
作者
Smith, JK [1 ]
Londono, A [1 ]
Castillo, M [1 ]
Kwock, L [1 ]
机构
[1] Univ N Carolina, Sch Med, Dept Radiol, Chapel Hill, NC 27599 USA
关键词
brain stem; magnetic; resonance spectroscopy;
D O I
10.1007/s00234-002.0821-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The imaging findings of brain-stem lesions are often nonspecific and histological diagnosis is limited because of fear of complications associated with biopsy. A noninvasive method for tissue characterization is therefore highly desirable. We undertook a review of proton magnetic resonance spectroscopy (MRS) of patients with solitary brain-stem lesions to determine if MRS could characterize them. We carried out single- or multivoxel proton MRS using long echo times (135 or 270 ins) on 34 patients with solitary brain-stem lesions. We analyzed the following peaks: choline (Cho), creatine (Cr), N-acetylaspartate (NAA), and lipids/lactate (Lip) and calculated peak height ratios for Cho/Cr, NAA/Cr and Lip/Cr. The results were compared with histology in nine patients and with the presumptive diagnosis in 25. We also performed single-voxel proton MRS on the brain stem of five normal volunteers. There were differences in all ratios between controls and the patients with neoplastic and non-neoplastic lesions: Cho/Cr was low in non-neoplastic and high in neoplastic lesions (control: 1.8 +/- 0.1; non-neoplastic: 1.4 +/- 0.2; neoplastic: 2.0 +/- 0.2); NAA/Cr was low in non-neoplastic, and lower in neoplastic lesions (control: 2.3 +/- 0.1; non-neoplastic: 1.4 0.2; neoplastic: 1.2 +/- 10.1), and Lip/Cr was elevated in both neoplastic and non-neoplastic lesions (control: 0.04 +/- 0.02; nonneoplastic: 1.9 +/- 0.7; neoplastic: 1.9 +/- 0.7).
引用
收藏
页码:825 / 829
页数:5
相关论文
共 10 条
[1]  
Bitsch A, 1999, AM J NEURORADIOL, V20, P1619
[2]   RESPONSE OF NON-HODGKIN-LYMPHOMA TO RADIATION-THERAPY - EARLY AND LONG-TERM ASSESSMENT WITH H-1 MR SPECTROSCOPIC IMAGING [J].
BIZZI, A ;
MOVSAS, B ;
TEDESCHI, G ;
PHILLIPS, CL ;
OKUNIEFF, P ;
ALGER, JR ;
DICHIRO, G .
RADIOLOGY, 1995, 194 (01) :271-276
[3]  
Cecil K M, 2001, Top Magn Reson Imaging, V12, P435, DOI 10.1097/00002142-200112000-00005
[4]  
DANIELSEN ER, 1999, MAGNETIC RESONANCE S, P80
[5]  
Krouwer HGJ, 1998, AM J NEURORADIOL, V19, P1695
[6]  
Kwock L, 1997, AM J NEURORADIOL, V18, P1349
[7]  
Rand SD, 1997, AM J NEURORADIOL, V18, P1695
[8]   Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis [J].
Taylor, JS ;
Langston, JW ;
Reddick, WE ;
Kingsley, PB ;
Ogg, RJ ;
Pui, MH ;
Kun, LE ;
Jenkins, JJ ;
Chen, G ;
Ochs, JJ ;
Sanford, RA ;
Heideman, RL .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (05) :1251-1261
[9]   Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors [J].
Tien, RD ;
Lai, PH ;
Smith, JS ;
Lazeyras, F .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1996, 167 (01) :201-209
[10]  
Tzika AA, 2002, AM J NEURORADIOL, V23, P322